metformin has been researched along with Periapical Diseases in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Periapical Diseases: Diseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the TOOTH ROOT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, EH | 1 |
| Yang, CN | 1 |
| Lin, SK | 1 |
| Wang, HW | 1 |
| Kok, SH | 1 |
| Hong, CY | 1 |
| Su, IH | 1 |
| Yang, H | 1 |
| Chang, JZ | 1 |
1 other study available for metformin and Periapical Diseases
| Article | Year |
|---|---|
Metformin Ameliorates Periapical Lesions through Suppression of Hypoxia-induced Apoptosis of Osteoblasts.
Topics: Animals; Apoptosis; Caspase 9; Cell Hypoxia; Cells, Cultured; Cytochromes c; Depression, Chemical; D | 2018 |